GOSERELIN | GOSERELIN | ATC L02AE03
ANTINEOPLASTIC PROSTATE CANCER (THERAPEUTIC) GONADOTROPIN RELEASING HORMONE (GNRH) AGONIST INHIBITS PITUITARY GONADOTROPIN SECRETION | IMPLANTATION | Cmax 2.23 NANOMOLAR VD 20.3 LITER PPB 27.3 PERCENT Cl 9.78 LITER / HOUR HT 1.4 HOUR (EQN) SOLUBILITY SOLUBLE IN WATER | GONADOTROPIN-RELEASING HORMONE RECEPTOR | Gonadotropin-releasing hormone receptor UNIPROT P30968 GNRHR more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |